Foghorn Therapeutics Inc. announced the election of Thomas Lynch Jr., M.D., to its Board of Directors. Dr. Thomas J. Lynch, Jr. is president and director of Fred Hutchinson Cancer Center and holder of the Raisbeck Endowed Chair, and sets the strategic direction of the center, oversees center-wide initiatives, and represents the Fred Hutch's interests to major partners and governmental bodies. Prior to his role at Fred Hutch, Dr. Lynch served as Chief Scientific Officer at Bristol-Myers Squibb.

Prior to that he held several leadership and clinician roles as director of Yale Cancer Center, physician in chief at Smilow Cancer Hospital, and chief of hematology-oncology at Massachusetts General Hospital.